Lekha George is a Nephrology physician. OpenAlex indexes 22 publications with 330 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1325 Eastmoreland,
Suite 360
Memphis, TN 381047514
Telephone
901-448-7782Provider last certified this registry record 25 Jan 2023.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Vantive US Healthcare LLCProgram year20252 payments
- Vifor Pharma, Inc.Program year20251 payment
- Mallinckrodt Hospital Products Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.1%Loop diuretic23.7%Furosemide71%Bumetanide29%Part D<11 patientsBeta blocker9.6%Carvedilol100%Part D≥13 patients+ 3 more classes in this area
Other
36.2%Drugs for treatment of hyperkalemia and hyperphosphatemia23.2%Velphoro79%Auryxia21%Part D<11 patientsPhosphate Binder13%Sevelamer Carbonate100%Part D≥18 patientsGenitourinary & hormones
7.1%alpha-Adrenergic Blocker7.1%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-18342-ACC HUGHES-STOVIN SYNDROME: CONTAINED PULMONARY ARTERY ANEURYSM RUPTURE MANAGED WITH ENDOVASCULAR REPAIR
Journal of the American College of Cardiology
2026 - When Potassium Won't Budge: Unraveling Hypertension and Ectopic ACTH Syndrome in a Case of Severe Hypercortisolism
Journal of the American Society of Nephrology
2025 - C3 Glomerulonephritis Unmasked: Navigating the Diagnostic Maze and Treatment Landscape
Journal of the American Society of Nephrology
2025 - Comparative Effectiveness of On-Pump Versus Off-Pump Coronary Surgical Revascularization Related to Postoperative Acute Kidney Injury
The American Journal of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”